Stroke:脑静脉血栓形成

2020-12-07 MedSci原创 MedSci原创

芬兰CVT总发病率与荷兰和澳大利亚的报告相似。入院率每年增加5.0%,而院内死亡率较低。男女之间的特定性别发病率明显不同。长期死亡率随年龄增长而增加,且男性较高。

据报道,脑静脉血栓形成(CVT)的流行病学特征正在改变。由于需要长期的全国性数据来确认这一种变化,近日,血管疾病领域权威杂志Stroke上发表了一篇研究文章,研究人员分析了2005年至2014年期间在芬兰发生的CVT病例数据。

研究人员从覆盖芬兰大陆的强制性登记处获取了所有急性CVT入院的患者,纳入了年龄≥18岁的患者。

研究人员确定了563例CVT患者(女性占56.5%)。每年的总发病率为1.32人/10万(95%CI为1.21–1.43),年增长率为5.0%。在55岁以下的人群中,男性的发病率为0.92人/100000人(0.76-1.10),女性为1.65人/100000人(1.43-1.89),而55岁以上人群,男性发病率为1.61(1.34-1.91),女性为1.17(0.96-1.41)。住院死亡率为2.1%,无性别差异。一年死亡率为7.9%。男性(调整后的风险比为1.61[1.09–2.38])和老年患者的长期死亡率较高(每增加10岁为1.95 [1.69–2.24])。

由此可见,芬兰CVT总发病率与荷兰和澳大利亚的报告相似。入院率每年增加5.0%,而院内死亡率较低。男女之间的特定性别发病率明显不同。长期死亡率随年龄增长而增加,且男性较高。

原始出处:

Jori O. Ruuskanen,et al.Cerebral Venous Thrombosis Finnish Nationwide Trends.stroke.2020.https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.031026

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1698174, encodeId=811c16981e459, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Mar 05 02:26:36 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947795, encodeId=2d1d94e7955d, content=欧洲学者随随便便就能动用全国数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77982249469, createdName=killer1111, createdTime=Sat Mar 13 07:30:04 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955522, encodeId=57b91955522c5, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 05 17:26:36 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483301, encodeId=a4be148330162, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Wed Dec 09 05:26:36 CST 2020, time=2020-12-09, status=1, ipAttribution=)]
    2021-03-05 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1698174, encodeId=811c16981e459, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Mar 05 02:26:36 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947795, encodeId=2d1d94e7955d, content=欧洲学者随随便便就能动用全国数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77982249469, createdName=killer1111, createdTime=Sat Mar 13 07:30:04 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955522, encodeId=57b91955522c5, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 05 17:26:36 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483301, encodeId=a4be148330162, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Wed Dec 09 05:26:36 CST 2020, time=2020-12-09, status=1, ipAttribution=)]
    2021-03-13 killer1111

    欧洲学者随随便便就能动用全国数据

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1698174, encodeId=811c16981e459, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Mar 05 02:26:36 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947795, encodeId=2d1d94e7955d, content=欧洲学者随随便便就能动用全国数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77982249469, createdName=killer1111, createdTime=Sat Mar 13 07:30:04 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955522, encodeId=57b91955522c5, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 05 17:26:36 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483301, encodeId=a4be148330162, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Wed Dec 09 05:26:36 CST 2020, time=2020-12-09, status=1, ipAttribution=)]
    2021-08-05 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1698174, encodeId=811c16981e459, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Mar 05 02:26:36 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947795, encodeId=2d1d94e7955d, content=欧洲学者随随便便就能动用全国数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77982249469, createdName=killer1111, createdTime=Sat Mar 13 07:30:04 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955522, encodeId=57b91955522c5, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Aug 05 17:26:36 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483301, encodeId=a4be148330162, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Wed Dec 09 05:26:36 CST 2020, time=2020-12-09, status=1, ipAttribution=)]

相关资讯

Stroke:急诊脑静脉血栓形成的误诊分析!

由此可见,在一个大型的、异质的多状态队列中,30例患者中有1例可能出现CVT误诊,但与不良临床结局无关。

Stroke:脑静脉血栓形成的再通

由此可见,接受抗凝治疗的患者的再通率总体上高达85%,未进行静脉再通与较差的临床结局相关。

Neurology:脑静脉血栓形成的迟发性发作

在2年的中位随访期间,约有十分之一的CVT患者出现LS。基线颅内出血、急性症状性癫痫发作和接受去骨瓣减压术的患者发生LS的风险增加。

欧洲卒中组织脑静脉血栓形成诊断和治疗指南

目前的脑静脉血栓形成(cerebral venous thrombosis,CVT)诊断和管理指南由2010 年欧洲神经病学联盟和2011 年美国心脏学会和美国卒中学会制定。上述指南依据传统方法,结合具有科学证据的综述和专家意见,然后用矩阵模型结合推荐意见分类和关于证据分级系统,对证据和推荐意见进行分类。2010 -2011 年以来,CVT 的诊断和管理已经在多方面积累了新的证据。笔者的目的是用更

Stroke:产后期是脑静脉血栓形成的危险因素

由此可见,最近分娩的女性患CVT的风险增加,而怀孕期间CVT的风险似乎并未增加。

Neurology:脑静脉血栓形成的急性症状性发作

1/3的CVT患者会发生ASS,并与脑实质病变和血栓形成有关。研究人员发现ASS与患者结局之间没有关联。